Home › Funds › Geode Capital Management › ANRO
Geode Capital Management position in ANRO
ALTO NEUROSCIENCE INC · Health Care
Latest position (Q2 2026)678.20K sh
Reported value held$17.90M
Portfolio Weight0.00%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 86.14K | $1.32M | New |
| Q2 2024 | 188.97K | $2.02M | Add |
| Q3 2024 | 469.99K | $5.38M | Add |
| Q4 2024 | 472.66K | $2.00M | Add |
| Q1 2025 | 486.86K | $1.05M | Add |
| Q2 2025 | 229.72K | $505.64K | Reduce |
| Q3 2025 | 237.90K | $956.86K | Add |
| Q4 2025 | 287.44K | $5.12M | Add |
| Q1 2026 | 292.90K | $6.59M | Add |
| Q2 2026 | 678.20K | $17.90M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANRO
- BlackRock Inc 2.12M sh · $55.97M · Q2 2026
- Franklin Resources 1.01M sh · $26.74M · Q2 2026
- Vanguard Group 1.37M sh · $24.31M · Q4 2025
- Northern Trust Corp 632.70K sh · $16.70M · Q2 2026
- Millennium Management 558.32K sh · $14.73M · Q2 2026
- Point72 Asset Management 502.95K sh · $13.27M · Q2 2026
- Goldman Sachs Group 236.83K sh · $6.25M · Q2 2026
- Marshall Wace 225.50K sh · $5.95M · Q2 2026
- Two Sigma Investments 147.30K sh · $3.89M · Q2 2026
- Alkeon Capital Management 102.10K sh · $2.69M · Q2 2026
- Charles Schwab Investment Management 80.58K sh · $2.13M · Q2 2026